Literature DB >> 3041023

Point mutation in the S gene of hepatitis B virus for a d/y or w/r subtypic change in two blood donors carrying a surface antigen of compound subtype adyr or adwr.

H Okamoto, M Imai, F Tsuda, T Tanaka, Y Miyakawa, M Mayumi.   

Abstract

Genomes of hepatitis B virus (HBV) were cloned from the plasma of a blood donor who carried subviral particles of three distinct subtypes in the following proportions: adr, 25%; ayr, 63%; and adyr, 12%. HBV DNA clones were classified into two groups based on a difference at only one nucleotide in the S gene. Two clones had A as nucleotide 365 that formed part of the codon for lysine as amino acid residue 122 and produced a surface antigen of subtype adr in transfected NIH 3T3 cells. The remaining four clones had G determining the codon for arginine and produced a surface antigen of subtype ayr in transfected cells. Similarly, HBV genomes were cloned from the plasma of an individual who carried subviral particles of subtypes adr (71%) and adwr (29%). Two clones had T and A as nucleotides 476 and 479, respectively. The other seven clones had C and G as the respective nucleotides. Based on a comparison with previously reported HBV genomes of various subtypes, the mutation of nucleotide 479, forming part of the codon for lysine or arginine as amino acid residue 160, was deduced to determine the w or r subtype, respectively. When NIH 3T3 cells were transfected separately with the genome of subtype adw or adr, derived from plasma containing a surface antigen of subtype adwr, and then cocultured, they produced subviral particles of either subtype adw or adr. When cells were transfected with the genomes of subtypes adw and adr simultaneously, however, subviral particles were produced that possessed w and r determinants on the selfsame particles. These results attributed the d/y or w/r subtypic change to a point mutation in the S gene and favored coinfection of hepatocytes with an HBV genome and its mutant as the mechanism of compound subtypes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3041023      PMCID: PMC255876          DOI: 10.1128/JVI.61.10.3030-3034.1987

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Geographical distribution of Australia antigen determinants d, y and w.

Authors:  S Mazzur; S Burgert; B S Blumberg
Journal:  Nature       Date:  1974-01-04       Impact factor: 49.962

2.  Subspecificities of the Australia antigen complex.

Authors:  G L Le Bouvier
Journal:  Am J Dis Child       Date:  1972-04

3.  Detection of additional antigenic determinants of hepatitis B antigen.

Authors:  W H Bancroft; F K Mundon; P K Russell
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

4.  Determination and distribution of two types of hepatitis-associated antigen.

Authors:  H J van Kok-Doorschodt; R van den Akker; R Gispen
Journal:  J Infect Dis       Date:  1972-08       Impact factor: 5.226

5.  The heterogeneity of Australia antigen.

Authors:  G L Le Bouvier
Journal:  J Infect Dis       Date:  1971-06       Impact factor: 5.226

6.  Letter: Ergasteric hepatitis from tissue with Australia antigen.

Authors:  M Mayumi; M Nakajima
Journal:  Ann Intern Med       Date:  1973-10       Impact factor: 25.391

7.  Replication of the genome of a hepatitis B--like virus by reverse transcription of an RNA intermediate.

Authors:  J Summers; W S Mason
Journal:  Cell       Date:  1982-06       Impact factor: 41.582

8.  Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.

Authors:  P J Southern; P Berg
Journal:  J Mol Appl Genet       Date:  1982

Review 9.  Rapid evolution of RNA genomes.

Authors:  J Holland; K Spindler; F Horodyski; E Grabau; S Nichol; S VandePol
Journal:  Science       Date:  1982-03-26       Impact factor: 47.728

10.  Hepatitis B virus genes and their expression in E. coli.

Authors:  M Pasek; T Goto; W Gilbert; B Zink; H Schaller; P MacKay; G Leadbetter; K Murray
Journal:  Nature       Date:  1979-12-06       Impact factor: 49.962

View more
  42 in total

1.  Establishment of transgenic mouse harboring hepatitis B virus (adr subtype) genomes.

Authors:  Y P Hu; W J Hu; W C Zheng; J X Li; D S Dai; X M Wang; S Z Zhang; H Y Yu; W Sun; G R Hao
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

2.  Follow up of infection of chacma baboons with inoculum containing A and non-A genotypes of hepatitis B virus.

Authors:  Marina Baptista; Anna Kramvis; Saffie Jammeh; Jocelyn Naicker; Jacqueline S Galpin; Michael C Kew
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

Review 3.  Hepatitis B virus. New and evolving issues.

Authors:  B Yoffe; C A Noonan
Journal:  Dig Dis Sci       Date:  1992-01       Impact factor: 3.199

4.  Reactivation of resolved hepatitis B virus infection with immune escape mutations after long-term corticosteroid therapy.

Authors:  Jun Inoue; Yasuteru Kondo; Yuta Wakui; Takayuki Kogure; Tatsuki Morosawa; Yasuyuki Fujisaka; Teruyuki Umetsu; Satoshi Takai; Takuya Nakamura; Tooru Shimosegawa
Journal:  Clin J Gastroenterol       Date:  2016-02-26

5.  Effects of vaccine-acquired polyclonal anti-HBs antibodies on the prevention of HBV infection of non-vaccine genotypes.

Authors:  Masaki Kato; Susumu Hamada-Tsutsumi; Chiaki Okuse; Aiko Sakai; Nobuyuki Matsumoto; Masaaki Sato; Toshiyuki Sato; Mitsumi Arito; Kazuki Omoteyama; Naoya Suematsu; Kazuki Okamoto; Takanobu Kato; Fumio Itoh; Ryo Sumazaki; Yasuhito Tanaka; Hiroshi Yotsuyanagi; Tomohiro Kato; Manae Suzuki Kurokawa
Journal:  J Gastroenterol       Date:  2017-02-14       Impact factor: 7.527

6.  Classifying genotype F of hepatitis B virus into F1 and F2 subtypes.

Authors:  Hideaki Kato; Kei Fujiwara; Robert G Gish; Hiroshi Sakugawa; Hiroshi Yoshizawa; Fuminaka Sugauchi; Etsuro Orito; Ryuzo Ueda; Yasuhito Tanaka; Takanobu Kato; Yuzo Miyakawa; Masashi Mizokami
Journal:  World J Gastroenterol       Date:  2005-10-28       Impact factor: 5.742

7.  Sequence analysis of pre-S/S gene of hepatitis B virus strains of genotypes A, D, and F isolated in Brazil.

Authors:  M T Moraes; S A Gomes; C Niel
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

8.  A novel hepatitis B virus mutant with A-to-G at nt551 in the surface antigen gene.

Authors:  Hua-Biao Chen; De-Xing Fang; Fa-Qing Li; Hui-Ying Jing; Wei-Guo Tan; Su-Qin Li
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

9.  Hybrid hepatitis B virus nucleocapsid bearing an immunodominant region from hepatitis B virus surface antigen.

Authors:  G Borisova; B Arya; A Dislers; O Borschukova; V Tsibinogin; D Skrastina; M A Eldarov; P Pumpens; K G Skryabin; E Grens
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

10.  Hepatitis B virus infection in children of HBV-related chronic liver disease patients: a study of intra-familial HBV transmission.

Authors:  Hartono Gunardi; Melanie Y Iskandar; Susan I Ie; Pramita G Dwipoerwantoro; Rino A Gani; David H Muljono
Journal:  Hepatol Int       Date:  2016-09-13       Impact factor: 6.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.